Loading
Retractable Technologies Inc Stock: price and insider trades · United States
No insider purchase over the last 90 days. The latest was filed 17 Nov 2025.
Retractable Technologies Inc: what insiders have been doing
This page follows insider dealings at Retractable Technologies Inc as filed with SEC (Form 4), a company from the Technology sector. In the past year (18 October 2025 to 18 October 2026), 8 filings came from 1 insider.
Every open-market trade in the period is a purchase: 8 purchases worth €84k, from 1 insider, and not a single sale. Unlike grants, an open-market purchase is paid for by the insider, at the market price. One trade stands out by size: a purchase of €28k from Shaw Thomas J, disclosed on 28 October 2025. Among those who bought: 1 chief executive.
With 8 filings in twelve months, the company is quieter than the median of 19 filings across the 5,814 companies we follow on the same exchange. Since 2022, the database holds 159 purchases and 3 sales by insiders of the company. In its latest annual report filed with the SEC (10-K, fiscal year ended 31 December 2025), the company reported revenue of 38.3 m USD and net income of -12.6 m USD.
The last purchase on record was published on 17 November 2025, which is 335 days ago. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 1 day. Section 16 rules allow two business days to file each Form 4.
For comparison within the same sector, see the insider buying recorded at Core Scientific, Inc./tx and Gitlab Inc. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Insider Decl.
162
Thresholds
n/a
Buy Volume
€2M
159 ops. · all time
Sell Volume
€5M
3 ops. · all time
Who traded when
BuySaleThomas J. Shaw75 buys
Since the insiders bought
- -14.5%Entry US$0.83 · Close at T+90 US$0.71
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Fundamental score
Ranked 23,925 of 24,148 companies
6.8
score / 100
Value5
Quality9
FCF yld-37%
Earn yld-62%
EV/EBITDA·
ROE-8.6%
Gross mgn0.1%
Net mgn-33%
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2025FY ended December 2025 · cache
US$0.68
Analyst consensus
Income statement
RevenueUS$38.3M
Gross profitUS$47k0% margin
EBITDA-US$4.4M-12% margin
Net income-US$12.6M-16.9% margin
Valuation
P/Book0.3x
Beta1.21
Balance sheet & cash
Market capUS$20.3M
Total debtUS$895.6k
Free Cash Flow-US$7.6M
Debt / Equity2%
Profitability & ownership
ROE-8.6%
ROA-9.5%
% insiders59.2%
% institutions8.4%
Last declaration on 17 November 2025
Declarations162 total
5,731 shares@ US$0.7720.3% of flowCommon StockSEC:0001174567-25-000016:0
Canonical exit: 12 Feb 2026 (T+90)
100 shares@ US$0.81110.0% of flowCommon StockSEC:0001174567-25-000015:0
Canonical exit: 9 Feb 2026 (T+90)
7,500 shares@ US$0.8260.5% of flowCommon StockSEC:0001174567-25-000014:0
Canonical exit: 3 Feb 2026 (T+90)
15,000 shares@ US$0.8611.0% of flowCommon StockSEC:0001174567-25-000012:0
Canonical exit: 28 Jan 2026 (T+90)
35,000 shares@ US$0.91512.5% of flowCommon StockSEC:0001174567-25-000011:0
Canonical exit: 26 Jan 2026 (T+90)
34,506 shares@ US$0.94252.5% of flowCommon StockSEC:0001174567-25-000010:0
Canonical exit: 25 Jan 2026 (T+90)
356 shares@ US$0.9510.0% of flowCommon StockSEC:0001174567-25-000009:0
Canonical exit: 21 Jan 2026 (T+90)
10,000 shares@ US$0.960.7% of flowCommon StockSEC:0001174567-25-000008:0
Canonical exit: 20 Jan 2026 (T+90)
14,204 shares@ US$0.92561.0% of flowCommon StockSEC:0001174567-25-000007:0
Canonical exit: 12 Jan 2026 (T+90)
30,000 shares@ US$0.92332.1% of flowCommon StockSEC:0001174567-25-000006:0
Canonical exit: 6 Jan 2026 (T+90)
5,000 shares@ US$0.82010.3% of flowCommon StockSEC:0001174567-25-000005:0
Canonical exit: 28 Dec 2025 (T+90)
17,500 shares@ US$0.8021.1% of flowCommon StockSEC:0001174567-25-000004:0
Canonical exit: 23 Dec 2025 (T+90)
2,500 shares@ US$0.8150.2% of flowCommon StockSEC:0001174567-25-000003:0
Canonical exit: 22 Dec 2025 (T+90)
3,000 shares@ US$0.7820.2% of flowCommon StockSEC:0001415889-25-023623:0
Canonical exit: 2 Dec 2025 (T+90)
5,500 shares@ US$0.8030.3% of flowCommon StockSEC:0001415889-25-023484:0
Canonical exit: 1 Dec 2025 (T+90)
9,042 shares@ US$0.79630.6% of flowCommon StockSEC:0001415889-25-022417:0
Canonical exit: 17 Nov 2025 (T+90)
32,935 shares@ US$0.7952.0% of flowCommon StockSEC:0001415889-25-022238:0
Canonical exit: 16 Nov 2025 (T+90)
3,103 shares@ US$0.78750.2% of flowCommon StockSEC:0001415889-25-022185:0
Canonical exit: 12 Nov 2025 (T+90)
3,983 shares@ US$0.80150.2% of flowCommon StockSEC:0001415889-25-021763:0
Canonical exit: 11 Nov 2025 (T+90)
8,411 shares@ US$0.8230.5% of flowCommon StockSEC:0001415889-25-021567:0
Canonical exit: 10 Nov 2025 (T+90)
2,100 shares@ US$0.81180.1% of flowCommon StockSEC:0001415889-25-021471:0
Canonical exit: 9 Nov 2025 (T+90)
49,541 shares@ US$0.7472.8% of flowCommon StockSEC:0001415889-25-021387:0
Canonical exit: 5 Nov 2025 (T+90)
30,881 shares@ US$0.71571.7% of flowCommon StockSEC:0001415889-25-021046:0
Canonical exit: 2 Nov 2025 (T+90)
1,575 shares@ US$0.7030.1% of flowCommon StockSEC:0001415889-25-020932:0
Canonical exit: 30 Oct 2025 (T+90)
5,339 shares@ US$0.71470.3% of flowCommon StockSEC:0001415889-25-020821:0
Canonical exit: 29 Oct 2025 (T+90)
25 of 162 declarations
About Retractable Technologies Inc
Retractable Technologies Inc is a company focused on the development of medical devices, including syringes and injection systems. It is listed on the XNAS market.
Recent ranked signals in the same sector
Purchases our model currently ranks for the recommendations list.
All recommendations
